Julia G. Butchko, Chief Development & Technology Officer at Immunovant, Inc. (IMVT), bought 5,000 shares at $38.17 ($191K) on 2020-09-11, disclosed to the SEC on 2020-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |